A milder than usual U.S. flu season is masking a growing concern about widespread resistance to the antiviral drug Tamiflu and what that means for the nation's preparedness in case of a dangerous pandemic flu.
Tamiflu, the most commonly used influenza antiviral and the mainstay of the federal government's emergency drug stockpile, no longer works for the dominant flu strain circulating in much of the country, government officials said Tuesday. Of samples tested since October, almost 100% of the strain -- known as type A H1N1 -- showed resistance to Tamiflu.
In response, the Centers for Disease Control and Prevention issued new guidelines to physicians in December. Doctors were told to substitute an alternative antiviral, Relenza, for Tamiflu, or to combine Tamiflu with an older antiviral, rimantadine, if the H1N1 virus was the main strain circulating in their communities.
Each flu season, several types of flu viruses circulate, and various ones can dominate in different regions and times. Only the H1N1 virus is showing signs of Tamiflu resistance, CDC officials said, speaking at an influenza conference in Washington. Other flu viruses currently circulating are not Tamiflu-resistant. Each year, the three most prominent flu strains -- two type A's and one type B -- are chosen for the creation of the flu vaccine. Unlike last year, both of the A viruses matched this year's vaccine, although the B did not, officials said.
EDIT
http://www.latimes.com/features/health/la-sci-flu4-2009feb04,0,5270483.story